Windracers ULTRA, a dual-use autonomous heavy-lift aircraft, has completed a 1,000-kilometer flight in Alaska carrying anti-doping blood samples as part of a study examining whether medical samples can be transported over long distances by unmanned aircraft while maintaining their integrity.
The mission also marked the first Beyond Visual Line of Sight flight of the Windracers ULTRA in North America. The aircraft was operated by the Alaska Center for Unmanned Aircraft Systems Integration at the University of Alaska Fairbanks, with the International Testing Agency and Sysmex supporting the research project.
Autonomous Heavy-Lift Drone Completes 1,000 km BVLOS Mission
The flight took place on August 19, 2026, from Nenana Municipal Airport near Fairbanks, Alaska.
The Windracers ULTRA traveled approximately 1,000 kilometers during a mission lasting several hours.
ACUASI provided its ULTRA aircraft along with flight planning, operational and technical support for the mission. Windracers Operations personnel also supported ACUASI, the International Testing Agency and Sysmex during the flight.
The mission was designed specifically to determine whether anti-doping blood samples could withstand long-distance autonomous air transport without compromising their condition.
“The mission of Windracers is to push the boundaries of autonomous aviation in service completing our customers missions,” said Simon Muderack, CEO of Windracers.
“This flight, expertly managed by Cathy Cahill and the ACUASI team, did exactly that and, created a new benchmark of ULTRA performance while delivering a result for our partners ITA and Sysmex.”
Windracers ULTRA Provides Heavy-Lift Autonomous Aircraft Platform
The Windracers ULTRA used for the mission is a 10-meter fixed-wing autonomous aircraft constructed from aluminum.
The dual-use aircraft is designed for autonomous cargo operations and was used in this project to evaluate long-distance transportation of sensitive biological samples.
The study could provide another transportation option when conventional logistics are slower, unpredictable or difficult to organize.
The International Testing Agency has been investigating autonomous air cargo for several years as a possible way to transport anti-doping samples, including during major sporting events where timely laboratory delivery is important to testing operations.
Alaska Highlights Potential for Remote Medical Drone Logistics
The Alaska mission also demonstrated potential applications extending beyond anti-doping operations.
According to ACUASI Director Cathy Cahill, 82% of Alaska’s communities are not connected to the road network, creating logistical challenges for healthcare services and medical supplies.
“Looking at the efficacy of autonomous air cargo for medical test samples is incredibly important for Alaska because 82 percent of our communities are not on the road system, that means it’s very difficult to bring medical care and supplies into those communities to address issues,” Cahill said.
Cahill described a potential workflow in which healthcare personnel collect samples in a remote community, send them to a laboratory by UAV and receive required medication by drone while medical personnel are still present.
“If we can have nurses go into the community and take samples, send them back by UAV for analysis, determine what medications are needed and then send medications back by UAV before the nurses leave, that is a huge benefit in giving people the care they need, where they live and in a timely manner,” she said.
International Testing Agency Evaluates Sample Integrity
The research project is being led by the International Testing Agency, which provides independent anti-doping programs.
A central requirement of the study is determining whether long-range autonomous transportation affects blood samples used in anti-doping testing.
“Innovation is essential to addressing practical challenges in anti-doping, but it must always be underpinned by robust science and the highest standards of sample integrity and chain of custody,” said Benjamin Cohen, ITA Director General.
“Through this research, we are assessing whether drone technology can become a reliable additional option for transporting samples over long distances or across difficult terrain.”
Cohen said the research could also have applications outside sports by helping remote communities gain faster access to laboratory and medical services.
Sysmex Supports Medical Sample Research
Sysmex, a provider of clinical laboratory diagnostic and hematology systems, is supporting the project.
“Sysmex is proud to support this research, but what excites us most is what it signals beyond sport,” said Andy Hay, Chairman of the Board of Directors at Sysmex America.
“The same technology that can move a blood sample across 1,000 kilometres of Alaskan wilderness could one day bring timely diagnostics to patients in the world’s most remote communities.”
Researchers Will Compare Blood Samples After Flight
Completion of the autonomous heavy-lift drone mission represents the transportation phase of the study rather than its final conclusion.
The International Testing Agency will next compare measurements recorded before and after the flight.
Researchers will examine whether the journey produced any discernible changes to:
- White blood cell populations
- Red blood cell populations
- Blood cell indices relevant to the Athlete Biological Passport
The source material does not yet establish that blood-sample integrity was maintained during the flight. That determination will depend on the laboratory analysis now underway.
If the results confirm that blood samples can maintain their integrity during extended autonomous flights, the research could support additional transportation options for anti-doping organizations, major sporting events and potentially remote medical logistics.
The 1,000-kilometer mission demonstrates the long-range transportation capability of the Windracers autonomous heavy-lift drone while providing researchers with real-world data to determine whether sensitive medical samples can safely be carried over extended distances by autonomous aircraft.
Source: Provided project release from Windracers, ACUASI, ITA and Sysmex
No Replies to "Autonomous Heavy-Lift Drone Completes 1,000 km Flight Carrying Medical Blood Samples"